Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines
European Journal of Cancer2011Vol. 47(16), pp. 2396–2402
Citations Over Time
Elsa Curtit, P. Nouyrigat, Nadine Dohollou, E. Lévy, Alain Lortholary, Joseph Gligorov, T. Facchini, D Jaubert, Nicolas Maille, Xavier Pivot, Valerie Grange, L. Cals
Related Papers
- → Weekly docetaxel in the treatment of metastatic breast cancer(2008)22 cited
- Docetaxel (Taxotere): preclinical and general clinical information.(1999)
- → Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity(2012)14 cited
- → The plinabulin/docetaxel combination to mitigate the known safety concerns of docetaxel.(2016)3 cited
- TS-1 による術後補助療法中に発症しWeekly Docetaxel 療法により著効をみた胃癌腹膜播種の1 例(2005)